President Joe Biden’s recent prostate cancer diagnosis has sparked questions about potential cover-ups, but medical evidence suggests no nefarious delays. Here’s what we know:

Biden revealed a Stage 4 prostate cancer diagnosis in May 2025, with a Gleason score of 9/10 indicating highly aggressive cells. Medical experts clarify this score reflects tumor behavior——and such cancers often evade early detection. Routine prostate-specific antigen (PSA) tests, discouraged for men over 70, might have missed it even with regular screenings.

Critics questioned why the diagnosis emerged post-presidency, alleging a coordinated distraction from prior health controversies. However, oncologists note aggressive prostate tumors can develop rapidly or hide for years without symptoms. Dr. Ezekiel Emanuel, a Biden ally, suggested the cancer could have been growing undetected for a decade, but this aligns with known medical realities—not proof of concealment.

Claims of a multi-year cover-up lack substantiation. The Gleason system doesn’t measure disease duration, and late-stage diagnoses are common in elderly men due to screening guidelines. While Biden’s 2022 remark about “having cancer” referenced past skin cancers—not prostate—this has been publicly documented.

In short, Biden’s diagnosis fits patterns of age-related prostate cancer progression. Suspicion of deliberate concealment contradicts expert explanations about the disease’s unpredictability and screening limitations.